baber/WOPTO huggingface dataset:
Patent NZ-569921-A (NZ)
Title: Improved flow-through device for the treatment of a fluid and flow-through element used thereby
Inventor: PAUWELS BART HUBERT EDITH
IPC: B01D29/90
Filed: 2007-02-09
Abstract: A flow-through device for treating a fluid is disclosed. The device comprises a housing in the shape of a pot (2) with a lid (3) which has an inlet (4) and an outlet (5) for the fluid. The housing also has an exchangeable tubular flow-through element (6) which has a medium (7) for treating the fluid. The element fits against the lid and forms a separation between the space (12) on the inside of the element which is connected to the inlet and the space on the outside of the element which is connected to the outlet. In the space on the inside of the element opposite the inlet, there is a tube (20) forming an extension of the inlet. The tube mainly extends in the axial direction (X-X') of the element and has lateral passages (21) for evenly distributing the fluid to be treated over the length of the flow-through element. The tube has a narrowing cross section, lengthwise in the axial direction of the flow of the fluid through the tube. The space on the outside of the element is connected to the outlet via a passage (17) in an annular flange (11) in the lid.
Patent NZ-572065-A (NZ)
Title: Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
Inventor: KAMISHITA TAIZOU
IPC: A61M11/00
Filed: 2007-04-20
Abstract: Disclosed herein is a gel-type skin/mucosa-adhesive preparation for administration from a spray device comprising a gel formulation which contains an active pharmaceutical ingredient in a gel base material, which gel base material comprises carboxy vinyl polymer and optionally gellan gum, wherein the viscosity of the preparation has been adjusted by adding an outside shearing force.
Patent NZ-577346-A (NZ)
Title: Pipe unblocker with visual temperature and rinsing indicator
Inventor: SEITA VICTOR
IPC: B08B3/08
Filed: 2009-06-02
Abstract: Disclosed is a liquid pipe unblocker comprising at least 80% by weight of one or more strong acids, and a coloured indicator assuming different colours in the range of pH of 0-1 given the acid concentration and the polarity of the pipe unblocker solution, wherein the coloured indicator is in the form of a carbocation in solution in the pipe unblocker of formula (I) wherein the substituents are disclosed within the specification. Preferably the coloured indicator is malachite green and has three colour changes in the pH range 0-1.
Patent NZ-579250-A (NZ)
Title: Food product
Inventor: PALMER DAVID
IPC: A23L1/00
Filed: 2009-08-25
Abstract: Raw meat 10 is sliced, packaged and sold in a container 20. The meat slices 12 are boiled in the container 20 until the meat is ready for serving. The container 20 also serves as a cooking and serving tray.
Patent NZ-581853-A (NZ)
Title: Sulfonyl-quinoline derivatives
Inventor: GALAMBOS JANOS
IPC: A61K31/4706
Filed: 2008-06-17
Abstract: Disclosed is a compound having the formula (I) e.g. 4-(4-chloro-phenyl)-3-(4-methyl-benzenesulfonyl)-quinoline wherein the substituents are defined in the specification and/or salts and/or hydrates and/or solvates thereof for the treatment and/or prevention of a disease selected from psychiatric disorders, neurological disorders, chronic and acute pain, neuromuscular dysfunctions of the lower urinary tract, gastrointestinal reflux disease, irritable bowel syndrome, substance abuse and withdrawal.
Patent NZ-584081-A (NZ)
Title: Permanent or sacrificial plastic shuttering for concrete
Inventor: JAYCOCK ANDREW PETER
IPC: E04B2/86
Filed: 2010-03-19
Abstract: A sacrificial shuttering 101 is in the form of an elongate plastics body with a base 103, a perpendicularly extending compression portion 104 and a strip cap portion 110 that is removably fitted on to the top edge 105 of the compression portion. Each of the base, compression, and cap portions is in the form of a hollow structure, and the top face 109 of the base and the side faces 108 of the compression portion are resiliently deformable surfaces so that the shutter can act as an integral compression joint between cast floor slabs or tilt-up wall slabs. The trick to using the shuttering is to place the base on wet mortar on top of a base course to lock the shutter to the base course as the mortar is held in the apertures 111, and then to cast the concrete within the confines of the base course and edges defined by the shutter.
Patent NZ-585912-A (NZ)
Title: Imitating natural plant fiber, preparation method thereof and fabric made of it
Inventor: CHEN HUNG-JEN
IPC: D03D15/50
Filed: 2007-11-27
Abstract: Disclosed herein is a manufacturing method for producing an imitating natural plant fiber, comprising the following steps: a) preparing the following materials for manufacturing masterbatches: (a1) plural first polyolefin chips (such as polypropylene), 10%-80% by weight based on the total weight of masterbatches, as a substrate; (a2) plural microcapsules, 5%-50% by weight based on the total weight of masterbatches, each of the microcapsules having at least one plant essential oil encapsulated therein; and (a3) a thermoplastic elastomer (TPE), 1%-80% based on the total weight of masterbatches; b) compounding the plural first polyolefin chips, the plural microcapsules and the thermoplastic elastomer to form plural masterbatches; c) providing the plural masterbatches and the plural second polyolefin chips, the second polyolefin being formed of the same material as the first polyolefin, and melting and mixing the plural masterbatches and the plural second polyolefin chips to form a composite material, such that the content of the plural microcapsules is in the amount of 1-32wt% based on the weight of the composite material; and d) processing the composite material into the fiber.
Patent NZ-586121-A (NZ)
Title: Benzimidazole derivatives as hedgehog pathway antagonists and therapeutic applications thereof
Inventor: THOMAS RUSSELL JOHN
IPC: C07D401/12
Filed: 2008-12-10
Abstract: Disclosed are compounds of formula I, pharmaceutically acceptable salts thereof, and methods for their preparation. Specific examples of compounds of formula I include: (2-{ 4-[3-(1H-Benzoimidazol-2-yl)-4-chloro-phenyl]-piperazin-l-yl} -ethyl)-dimethyl-amine, 4-[3-(1H-Benzoimidazol-2-yl)-phenyl]-piperazine-1-carboxylic acid tert-butyl ester, { 4-[3-(1-Methyl-1H-benzoimidazol-2-yl)-phenyl)piperazin-l-yl} -(4-methyl-morpholin-3-yl)-methanone, and { 4-[3-(1H-Benzoimidazol-2-yl)-4-chloro-phenyl][1,4]diazepan-1-yl} -(1-methyl-piperidin-3-yl-methanone. Also disclosed is the use of compounds of formula I for treating osteoporosis and cancer, where the cancer is selected from non-small cell lung carcinoma, small-cell lung cancer, breast cancer, ovarian tumours, digestive tract tumours, brain cancer, prostate cancer, pancreatic cancer, basal cell carcinoma, malignant melanoma, squamous cell carcinomas, multiple myeloma, lymphoma, mesenchymal cancers,chronic myeloid leukaemia, endometrial carcinoma, and hepatocellular carcinoma.
Patent NZ-588083-A (NZ)
Title: Polysubstituted derivatives of 6-heteroaryl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof
Inventor: DE PERETTI DANIELLE
IPC: A61K31/4188
Filed: 2009-03-20
Abstract: Disclosed are 2-aryl-6-heteroaryl-imidazo[1,2-a]pyridine derivatives as represented by the general formula (I), wherein: R1 is phenyl, naphthyl, heteroaryl or a heterocyclic ring each of which may be optionally substituted; and wherein the remaining substituents are as defined herein. Representative compounds include those such as { 5-[2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]furan-2-yl methanol, [5-(2-quinolin-3-ylimidazo[1,2-a]pyridin-6-yl)furan-2-yl]methanol and the hydrochloride thereof, [4-(2-p-tolylimidazo[1,2-a]pyridin-6-yl)thien-2-yl]methanol, [2-(2-quinolin-3-ylimidazo[1,2-a]pyridin-6-yl)pyridin-4-yl]methanol and the hydrochloride thereof, 4-[6-(5-hydroxymethylfuran-2-yl)imidazo[1,2-a]pyridin-2-yl]-N,N-dimethylbenzamide, N-tert-butyl-5-[6-(5-hydroxymethylthien-3-yl)imidazo[1,2-a]pyridin-2-yl]nicotinamide, { 4-[2-(4-morpholin-4-ylphenyl)imidazo[1,2-a]pyridin-6-yl]thiazol-2-yl} methanol, [4-(2-isoquinolin-5-ylimidazo[1,2-a]pyridin-6-yl)thiazol-2-yl]methanol and N-{ 3-[6-(2-hydroxymethyl-thiazol-4-yl)imidazo[1,2-a]pyridin-2-yl]phenyl} isobutyramide. Further disclosed is a pharmaceutical composition, which comprises a compound of formula (I) as defined above or a pharmaceutically acceptable salt thereof and also at least one pharmaceutically acceptable excipient, for the treatment and prevention of neurodegenerative diseases, cerebral traumas, epilepsy, psychiatric diseases, inflammatory diseases, osteoporosis and / or cancers.
Patent NZ-600699-A (NZ)
Title: Systems and methods for analyzing event data
Inventor: EVANSEN EDWARD G
IPC: A63B71/02
Filed: 2011-01-05
Abstract: Disclosed is a computer-implemented method for determining a target situation in an event. The method includes receiving positional information including the relative positions of a first plurality of selected participants in the event. The method also includes detecting, in real-time, aggregate motion of the selected participants using the positional information. The method further includes determining that the target situation has occurred when at least one change in the aggregate motion occurs in accordance with a predetermined characteristic during a first time interval. The determined target situation may be the occurrence of a particular element of play in a team sport.
Patent NZ-601684-A (NZ)
Title: Salt of fused heterocyclic derivative and crystal thereof
Inventor: TAKEUCHI HIDEKI
IPC: A61K31/519
Filed: 2011-02-09
Abstract: Abstract - 601684 Disclosed is 3-[2-fluoro-5-(2,3-difluoro-6-methoxybenzyloxy)-4-methoxyphenyl]-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid choline salt in crystalline form. Also disclosed is a pharmaceutical composition which comprises as an active ingredient a crystalline salt as defined above, for the prevention or treatment of a sex hormone-dependent disease, a reproduction regulator, a contraceptive, an ovulation inducing agent, or an agent for the prevention of post-operative recurrence of sex hormone-dependent cancers.
Patent NZ-608551-A (NZ)
Title: Cushion for a respiratory mask assembly
Inventor: FRATER ROBERT HENRY
IPC: A61M16/06
Filed: 2005-06-15
Abstract: A respiratory mask assembly for treatment of sleep disordered breathing is disclosed. The mask comprises a frame (see 12, figure 1) and a cushion (232; see also 14, figure 1) which at least in part defines a cavity. The cushion provides an aperture capable of receiving at least a patient’s nose. The cushion includes a face contacting portion (236), a non-face contacting portion (234), a gusset portion (238) connected between the face contacting portion and the non-face contacting portion, and an air delivery connection supported by the frame and adapted to connect an air delivery conduit to supply air to the cavity. The gusset portion includes an underside notch (249) and is configured so that the cushion is less stiff at a nasal bridge region. When the mask is compressed against a user’s face, the notch will cause the walls of the cushion to collapse at the weakest point, allowing further travel of the mask toward and away from the user’s face.
Patent NZ-609636-A (NZ)
Title: Fibrous materials and compositions
Inventor: MEDOFF MARSHALL
IPC: B02C19/00
Filed: 2007-06-12
Abstract: The disclosure relates to a method of making a fuel, the method comprising: mechanically treating a fiber source to provide a first fibrous material; , passing a first fibrous material that has been prepared by shearing a cellulosic or lignocellulosic fiber source through a first screen having an average opening size of 1.59 mm or less (1/16 inch; 0.0625 inch) to provide a second fibrous material having a BET surface area greater than 0.1 m2/g and a porosity greater than 20 percent and an average length to diameter ratio greater than 5/1; and, combining the second fibrous material with a bacterium and/or enzyme to provide a fibrous material composition;, encapsulating the composition in a substantially gas impermeable material; and , removing entrapped gas from the encapsulated composition to densify the composition, , wherein the microorganism hydrolyzes the second fibrous material to produce a fuel selected from the group consisting of hydrogen, alcohols, organic acids, hydrocarbons, and mixtures thereof, and wherein the second fibrous material may be sterilized by exposing it to a radiation source prior to combining with the microorganism.
Patent NZ-614002-A (NZ)
Title: Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
Inventor: MOGNA GIOVANNI
IPC: A61K35/747
Filed: 2012-01-24
Abstract: Disclosed is a use of an effervescent composition in solid form comprising: an acid-base system comprising an organic acid and a salt of the carbonate and/or bicarbonate anion; the salt being present in an amount comprised from 1 to 15% by weight, relative to the total weight of the composition, a mixture comprising microcrystalline cellulose and arabinogalactan, - at least one probiotic bacterial strain having the ability to reduce and/or eliminate the presence of pathogenic agents selected from the group comprising: Candida albicans, Candida glabrata, Candida parapsilosis, Candida krusei, Candida tropicalis, Gardnerella vaginalis, Trichomonas vaginalis, Neisseria gonorrhoeae, Escherichia coli, Herpes simplex and Haemophilus ducreyi, in the manufacture of a medicament for vaginal applications for the treatment of vaginal infections.
Patent NZ-615184-A (NZ)
Title: Canola germplasm exhibiting seed compositional attributes that deliver enhanced canola meal nutritional value having omega-9 traits
Inventor: PATTERSON THOMAS G
IPC: A23L35/00
Filed: 2012-02-21
Abstract: Disclosed is a dark-seeded canola germplasm conferring on the seed of a canola plant the traits of: high protein content, as compared to a dark-seeded canola plant of the same species; low acid detergent fiber (ADF) content, as compared to a dark-seeded canola plant of the same species; and seed oil comprising at least 68% oleic acid (C18:1) and less than 3% linolenic acid (C18:3); and at least one additional trait selected from the group consisting of reduced polyphenolic content and increased phosphorous content, as compared to a dark-seeded canola plant of the same species.
Patent NZ-621638-A (NZ)
Title: Dna methylation in colorectal and breast cancer diagnostic methods
Inventor: MOLLOY PETER LAURENCE
IPC: C12Q1/68
Filed: 2012-08-24
Abstract: A method of screening for the onset or predisposition to the onset of a large intestine or breast neoplasm in an individual comprises assessing the methylation status of the DNA region defined by Hg19 coordinates Chr6: 163834097-163834982 in a biological sample from the individual. A higher level of methylation of the DNA region relative to control levels is indicative of a neoplastic large intestine or breast cell or a cell predisposed to the onset of a neoplastic state.
Patent NZ-701380-A (NZ)
Title: Multiplex immuno screening assay
Inventor: MANUGUERRA JEAN-CLAUDE
IPC: G01N33/564
Filed: 2013-05-03
Abstract: The present invention provides kits and assay methods for the early detection of pathogens, precise identification of the etiologic agent, and improved disease surveillance. More specifically, the present invention discloses an immunoassay leading to the rapid and simultaneous detection of antibodies to a wide range of infectious pathogens in biological fluids of infected patients. This immunoassay involves the covalent and oriented coupling of fusion proteins comprising an AGT enzyme and a viral antigen on an identifiable solid support (e.g. fluorescent microspheres), said support being previously coated with an AGT substrate. This coupling is mediated by the irreversible reaction of the AGT enzyme on its substrate. The thus obtained antigen-coupled microspheres show enhanced capture of specific antibodies as compared to antigen-coupled microspheres produced by standard amine coupling procedures. The methods of the invention possess the ability to multiplex, minimize the amount of biological sample, and have enhanced sensitivity and specificity toward target antibodies as compared with classical ELISA or Radio-Immunoprecipitation assays.
Patent NZ-720620-A (NZ)
Title: Compositions and methods for reducing major adverse cardiovascular events
Inventor: KLASSEN PRESTON
IPC: A61K31/485
Filed: 2014-12-04
Abstract: The present application relates to compositions, kits, uses, systems and methods of using naltrexone and bupropion, or pharmaceutically acceptable salts thereof, for reducing the risk of adverse cardiovascular outcomes or events, including Major Adverse Cardiovascular Events (MACE) in subjects, preferably those at increased risk of adverse cardiovascular outcomes or MACE, that may be overweight or obese. The present application also relates to compositions, kits, uses, systems and methods of using naltrexone and bupropion or pharmaceutically acceptable salts thereof for treatment of overweight or obesity in subjects, preferably at increased risk of adverse cardiovascular outcomes or MACE, wherein the treatment reduces the risk of MACE.
Patent NZ-720991-A (NZ)
Title: Systems and methods for creating and using a research map
Inventor: SHARMA SANJAY
IPC: G06F17/30
Filed: 2011-12-08
Abstract: Disclosed is a computer-implemented method of searching a document repository using a research map. The method comprises generating information used to display a research map, the information comprising search nodes, filter nodes, and document nodes; receiving a selection of a first filter node comprising a first document result list from a first research tree displayed in the research map; receiving a selection of a second filter node comprising a second document result list from a second research tree displayed in the research map; determining, by a processor, a third result list including documents from both the first document result list and the second document result list; and generating data to display the third result list.
Patent NZ-724237-A (NZ)
Title: Catheter structures for reducing fluoroscopy usage during endovascular procedures
Inventor: BAJEMA NICHOLAS
IPC: A61M25/095
Filed: 2015-03-31
Abstract: There is provided herein a kit for treating a treatment area in a vasculature of a patient. The kit comprises a guidewire having a portion for positioning at or near the treatment area and a portion with first markings perceptible by the clinician without fluoroscopy. Each of the first markings is representative of a length from a first starting point on the guidewire. The kit also comprises a catheter having a shaft with a portion for positioning at the treatment area and a portion with second markings perceptible by the clinician without fluoroscopy. Each of the second markings is representative of a length from a second starting point of the catheter. A distance between the first starting point and each of the first markings corresponds to a distance between the second starting point and each of the second markings. The catheter comprises a balloon and the second predetermined starting point is located at a proximal or distal end of the balloon.
Patent NZ-729618-A (NZ)
Title: Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds
Inventor: VENKATARAMANI CHANDRASEKAR
IPC: C07D498/04
Filed: 2015-09-23
Abstract: Compounds having the following formula (I) which may inhibit or otherwise modulate the activity of TANK-binding kinase (TBK1) and I-Kappa-B kinase (IKKe, IKBKE), and compositions and formulations containing such compounds, and methods of using and making such compounds:(I).
Patent NZ-742492-A (NZ)
Title: Syringe
Inventor: RA YONG-KUK
IPC: A61M39/22
Filed: 2016-10-27
Abstract: The present invention relates to a syringe, and more particularly, to an apparatus obtained by improving a conventional syringe formed with an injection flow passage including an injection needle, so as to share a portion of the injection flow passage except the injection needle or to form a suction flow passage completely independent of the injection flow passage, thereby further smoothing suction of a liquid medicine. The syringe includes an injection needle (10) and a cylinder (20) and is formed with an injection flow passage formed from the cylinder (20) to the injection needle (10). The syringe further includes an opening/closing means (400) for selectively opening or closing the injection flow passage; and a suction flow passage formed from a pointed hollow cap (100) to the cylinder (20) and provided with a through-hole formed in any one of the injection needle (10), a connector (500) for connecting the injection needle (10) to the cylinder (20), and the cylinder (20) to establish communication between an inside and an outside thereof and a one-way valve means (300) for intermittently controlling opening or closing of the through-hole. The syringe is configured such that the separate suction flow passage bypassing the injection needle is formed in a conventional syringe to more smoothly perform the suction of the liquid medicine.
Patent NZ-747201-A (NZ)
Title: (+)-azasetron for use in the treatment of ear disorders
Inventor: DYHRFJELD-JOHNSEN JONAS
IPC: A61P27/16
Filed: 2017-04-14
Abstract: The present invention relates to (+)-azasetron, or a pharmaceutically acceptable salt and/or solvate thereof, for treating ear disorders.
Patent NZ-747422-A (NZ)
Title: Activin-actrii antagonists and uses for treating bone and other disorders
Inventor: SLOAN VICTOR
IPC: A61P19/08
Filed: 2013-11-01
Abstract: Provided herein are methods for the treatment of bone disorders that are associated with kidney disease, in particular chronic kidney disease-mineral and bone disorder (CKD-MBD), wherein the methods comprise administration of Activin-ActRIIA inhibitors to a subject in need of the treatment. Also provided herein are methods and compositions for the treatment of low turnover bone disorders wherein the methods comprise administration of Activin-ActRIIA inhibitors to a subject in need of the treatment. Further provided herein are compositions for the treatment of bone disorders that are associated with kidney disease and compositions for the treatment of low turnover bone disorders and vascular calcification.
Patent NZ-749630-A (NZ)
Title: Method for carrying out an inventory of a plurality of biological containers and associated gantry
Inventor: MONGRENIER JEAN-CLAUDE
IPC: G06Q10/08
Filed: 2016-10-24
Abstract: The invention relates to a method for carrying out an inventory of a plurality of containers (16) of biological products, each container (16), and/or each package (14) comprising containers (16), being equipped with an identification label comprising a wireless communication chip. The method comprises the steps of: - providing a device (12) comprising a gantry (26) defining a direction of travel (X), - providing a receptacle (10) capable of being moved, the receptacle (10) carrying the plurality of containers (16), - moving the receptacle (10) in order to cross the gantry (26) in the direction of travel, and - reading the wireless communication chip of each container and/or package (14, 16) during movement of the receptacle (10).